Lumayag, Melchecedic L.

HRN: 05-63-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CEFTRIAXONE 1G (VIAL)
06/14/2025
06/21/2025
IV
2g
OD
Bilateral Pleural Effusion Prob Parapneumonic Vs PTB
Waiting Final Action 
06/14/2025
AZITHROMYCIN 500MG TABLET (TAB)
06/14/2025
06/19/2025
PO
500mg
OD
Bilateral Pleural Effusion Prob Parapneumonic Vs PTB
Waiting Final Action 
06/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/16/2025
06/22/2025
IV
1.5g
Q6h
CAPMR
Waiting Final Action 
06/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/16/2025
06/22/2025
IV
1.5g
Q6h
CAP-MR
Waiting Final Action 
06/18/2025
CLARITHROMYCIN 500MG (CAP)
06/18/2025
06/24/2025
PO
500 Mg
Bid
Pleural Effusion
Waiting Final Action 
07/01/2025
CIPROFLOXACIN 500MG (TAB)
07/01/2025
07/08/2025
PO
500mg
BID
CAP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: